Stay up-to-date with our latest news, blog articles, videos, and event announcements. Learn from business success stories and gain access to valuable e-books and resources.
FSN Capital VI (“FSNC”) has acquired all remaining shares held by Prange Group (“PG”) in Adragos Pharma Group (“Adragos Pharma”), an international contract development and manufacturing organisation (“CDMO”) for pharmaceuticals. In 2021, FSNC partnered with Prange Group to accelerate the […]
How to Choose a Sterile Fill-Finish CDMO When selecting a sterile fill-finish Contract Development and Manufacturing Organisation (CDMO), the most consequential evaluation criteria are regulatory compliance history, aseptic process technology, lyophilisation capability, clinical-to-commercial scalability, network redundancy, technology transfer rigour and […]
Sterile liquid manufacturing is unforgiving. A small lapse in control can become a patient risk, a batch disposition delay, an investigation that consumes weeks, or an interruption to supply. In that environment, in-process control (IPC) is not administrative overhead. It […]
A non-sterile liquid CDMO is the right partner for the products that do not need to be sterile: creams, gels, ointments and oral or topical liquids. These are the everyday medicines that make up a large share of most portfolios, […]
Choosing a CDMO for small batch injectables is one of the harder decisions in sterile drug development. A contract development and manufacturing organisation (CDMO) that suits a large commodity campaign is often the wrong fit for a small, high-value sterile […]
Moving clinical to commercial sterile injectables from trial batches to market supply is one of the most demanding transitions in drug manufacturing. This injectable pharmaceutical manufacturing scale-up has to increase batch size, line speed and annual volume while never weakening […]
Get notified on our latest news.
